Variant report
Variant | esv3404139 |
---|---|
Chromosome Location | chr3:22580548-22585046 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs193170663 | chr3:22580572-22580573 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571335574 | chr3:22580579-22580580 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538837775 | chr3:22580587-22580588 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547571214 | chr3:22580607-22580608 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565873947 | chr3:22580689-22580690 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17379077 | chr3:22580696-22580697 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs555505212 | chr3:22580709-22580710 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112036232 | chr3:22580718-22580719 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35669274 | chr3:22580727-22580728 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183319296 | chr3:22580780-22580781 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62253403 | chr3:22580784-22580785 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs1449896 | chr3:22580785-22580786 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs577669731 | chr3:22580805-22580806 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545206033 | chr3:22580808-22580809 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560728826 | chr3:22580828-22580829 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572699540 | chr3:22580840-22580841 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543287424 | chr3:22580894-22580895 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560757786 | chr3:22580900-22580901 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201968641 | chr3:22580937-22580938 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376899237 | chr3:22580952-22580953 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1449895 | chr3:22580956-22580957 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs114210911 | chr3:22580970-22580971 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367845914 | chr3:22580977-22580978 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11129075 | chr3:22581004-22581005 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs377291306 | chr3:22581028-22581029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529921872 | chr3:22581039-22581040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549405669 | chr3:22581059-22581060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs151165967 | chr3:22581092-22581093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563290261 | chr3:22581098-22581099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9854314 | chr3:22581102-22581103 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs189066234 | chr3:22581128-22581129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532118891 | chr3:22581158-22581159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531970217 | chr3:22581161-22581162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs67573843 | chr3:22581177-22581178 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs9874439 | chr3:22581221-22581222 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs535264562 | chr3:22581237-22581238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548479397 | chr3:22581293-22581294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569823597 | chr3:22581316-22581317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs193018905 | chr3:22581350-22581351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556099322 | chr3:22581376-22581377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12638304 | chr3:22581381-22581382 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs34955060 | chr3:22581388-22581389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs397942092 | chr3:22581397-22581398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368739312 | chr3:22581432-22581433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544417963 | chr3:22581455-22581456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537739916 | chr3:22581477-22581478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140240884 | chr3:22581504-22581505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372038912 | chr3:22581505-22581506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12630192 | chr3:22581523-22581524 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs572587662 | chr3:22581525-22581526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22579800-22581000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:22580400-22581000 | Active TSS | Pancreatic Islets | Pancreatic Islet |
3 | chr3:22581000-22584800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:22584800-22585200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |